Literature DB >> 10777674

Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins.

A Lookene1, M S Nielsen, J Gliemann, G Olivecrona.   

Abstract

The C-terminal domain of lipoprotein lipase (LPL) is involved in several important interactions. To assess its contribution to the binding ability of full-length LPL we have determined kinetic constants using biosensor technique. The affinity of the C-terminal domain for heparin was about 500-fold lower than that of full-length LPL (K(d) = 1.3 microM compared to 3.1 nM). Replacement of Lys403, Arg405 and Lys407 by Ala abolished the heparin affinity, whereas replacement of Arg420 and Lys422 had little effect. The C-terminal domain increased binding of chylomicrons and VLDL to immobilized heparin relatively well, but was less than 10% efficient in binding of LDL compared to full-length LPL. Deletion of residues 390-393 (WSDW) did not change the affinity to heparin and only slightly decreased the affinity to lipoproteins. We conclude that the C-terminal folding domain contributes only moderately to the heparin affinity of full-length LPL, whereas the domain appears important for tethering triglyceride-rich lipoproteins to heparin-bound LPL. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777674     DOI: 10.1006/bbrc.2000.2530

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 2.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

3.  Biochemical Analysis of the Lipoprotein Lipase Truncation Variant, LPLS447X, Reveals Increased Lipoprotein Uptake.

Authors:  Cassandra K Hayne; Michael J Lafferty; Brian J Eglinger; John P Kane; Saskia B Neher
Journal:  Biochemistry       Date:  2017-01-09       Impact factor: 3.162

Review 4.  The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.

Authors:  Geesje M Dallinga-Thie; Remco Franssen; Hans L Mooij; Maartje E Visser; H Carlijne Hassing; Frank Peelman; John J P Kastelein; Miklós Péterfy; Max Nieuwdorp
Journal:  Atherosclerosis       Date:  2009-12-29       Impact factor: 5.162

5.  Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries.

Authors:  Christopher M Allan; Mikael Larsson; Rachel S Jung; Michael Ploug; André Bensadoun; Anne P Beigneux; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

6.  Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes.

Authors:  Wieneke Dijk; Philip M M Ruppert; Lynette J Oost; Sander Kersten
Journal:  J Biol Chem       Date:  2018-07-18       Impact factor: 5.157

7.  Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.

Authors:  E P Lutz; M Merkel; Y Kako; K Melford; H Radner; J L Breslow; A Bensadoun; I J Goldberg
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 8.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

9.  On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.

Authors:  Oleg Kovrov; Kristian Kølby Kristensen; Erika Larsson; Michael Ploug; Gunilla Olivecrona
Journal:  J Lipid Res       Date:  2019-01-27       Impact factor: 5.922

10.  The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.

Authors:  Peter Gin; Liya Yin; Brandon S J Davies; Michael M Weinstein; Robert O Ryan; André Bensadoun; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.